Skip to content

PREVASC-OMEGA; Prevention of asthma in children at high risk of developing asthma.

PREVASC-OMEGA; Prevention of asthma in children at high risk of developing asthma by advising parents on reducing environmental exposures.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27477
Enrollment
443
Registered
2005-09-23
Start date
1997-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

Advisory intervention on reducing exposure to: Allergen exposure (house dust mite, cat and dog allergens)
Food allergens by exclusively breastfeeding for a period of 6 months or if not possible feeding the child with hypo-allergenic formula, introducing solids until 6 months
Environmental tobacco smoke (parents stop smoking). Control group: usual care.

Sponsors

NAF (Dutch asthma foundation, sponsor) ZONmw (zorg onderzoek Nederland, sponsor) Maastricht University, initiator
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: General practitioners, midwives and gynaecologists were instructed to check the inclusion criteria: 1. Pregnant women <7months gestational age; 2. Unborn child at high risk of developing asthma on grounds of familial predisposition first degree; 3. Living in study region.

Exclusion criteria

Exclusion criteria: 1. Major language problem; 2. Intrauterine or neonatal death; 3. Moving outside The Netherlands; 4. Severe illness/malformation child.

Design outcomes

Primary

MeasureTime frame
Current Asthma 6 yrs as measured in lung function laboratory combined with asthma complaints as registered by General Practitioner and/or parents (questionnaires).

Secondary

MeasureTime frame
Asthma diagnosis by General Practitioner; asthma symptoms 0-6yrs (questionnaires); asthma symptoms 0-6 yrs (General practitioner); hospital admission for asthma symptoms; allergy (as registered by parents, general practitioner, IgE measurements project).

Contacts

Public ContactTanja Maas

University Maastricht (UM), Department of General Practice, P.O. Box 616

tanja.maas@hag.unimaas.nl+31 (0)43 3882169

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)